PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 79 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $182,659 | -25.6% | 69,452 | -0.2% | 0.00% | – |
| Q2 2023 | $245,671 | +13.8% | 69,595 | -0.4% | 0.00% | – |
| Q1 2023 | $215,809 | -23.2% | 69,841 | +5.1% | 0.00% | – |
| Q4 2022 | $281,024 | +72.4% | 66,436 | -3.6% | 0.00% | – |
| Q3 2022 | $163,000 | -17.3% | 68,951 | -0.1% | 0.00% | – |
| Q2 2022 | $197,000 | -75.9% | 68,986 | -75.7% | 0.00% | – |
| Q1 2022 | $818,000 | -11.8% | 284,133 | -6.9% | 0.00% | – |
| Q4 2021 | $927,000 | -62.2% | 305,164 | -12.8% | 0.00% | – |
| Q3 2021 | $2,452,000 | -22.6% | 349,802 | +1.3% | 0.00% | -100.0% |
| Q2 2021 | $3,169,000 | -5.7% | 345,211 | -0.1% | 0.00% | 0.0% |
| Q1 2021 | $3,359,000 | -10.7% | 345,611 | -5.7% | 0.00% | 0.0% |
| Q4 2020 | $3,761,000 | +0.1% | 366,541 | -1.6% | 0.00% | 0.0% |
| Q3 2020 | $3,758,000 | -8.6% | 372,472 | -5.5% | 0.00% | 0.0% |
| Q2 2020 | $4,110,000 | +28.1% | 394,006 | +3.7% | 0.00% | 0.0% |
| Q1 2020 | $3,208,000 | -1.8% | 380,018 | +1.8% | 0.00% | 0.0% |
| Q4 2019 | $3,267,000 | -21.7% | 373,441 | -3.6% | 0.00% | 0.0% |
| Q3 2019 | $4,172,000 | -7.9% | 387,513 | +8.7% | 0.00% | 0.0% |
| Q2 2019 | $4,530,000 | -67.1% | 356,356 | +0.4% | 0.00% | -66.7% |
| Q1 2019 | $13,765,000 | +91.7% | 354,879 | +0.6% | 0.00% | +50.0% |
| Q4 2018 | $7,181,000 | -56.0% | 352,885 | -0.9% | 0.00% | -50.0% |
| Q3 2018 | $16,323,000 | -20.7% | 356,007 | +2.3% | 0.00% | -20.0% |
| Q2 2018 | $20,593,000 | -11.4% | 348,150 | +1.9% | 0.01% | -16.7% |
| Q1 2018 | $23,247,000 | -30.2% | 341,614 | +1.5% | 0.01% | -25.0% |
| Q4 2017 | $33,285,000 | -19.6% | 336,727 | -2.6% | 0.01% | -27.3% |
| Q3 2017 | $41,417,000 | +36.3% | 345,860 | -0.5% | 0.01% | +37.5% |
| Q2 2017 | $30,386,000 | +144.2% | 347,665 | +3.9% | 0.01% | +100.0% |
| Q1 2017 | $12,444,000 | +23.0% | 334,508 | +1.5% | 0.00% | +33.3% |
| Q4 2016 | $10,117,000 | -45.3% | 329,526 | +19.4% | 0.00% | -50.0% |
| Q3 2016 | $18,497,000 | +127.7% | 275,871 | +1.2% | 0.01% | +100.0% |
| Q2 2016 | $8,124,000 | +198.6% | 272,695 | +194.7% | 0.00% | +200.0% |
| Q1 2016 | $2,721,000 | -62.2% | 92,528 | +0.9% | 0.00% | -50.0% |
| Q4 2015 | $7,190,000 | -27.1% | 91,719 | -29.9% | 0.00% | -33.3% |
| Q3 2015 | $9,863,000 | -71.1% | 130,876 | -55.2% | 0.00% | -70.0% |
| Q2 2015 | $34,073,000 | -44.9% | 291,844 | +11.4% | 0.01% | -47.4% |
| Q1 2015 | $61,871,000 | +29.9% | 262,042 | +4.1% | 0.02% | +35.7% |
| Q4 2014 | $47,641,000 | -23.6% | 251,710 | -3.7% | 0.01% | -30.0% |
| Q3 2014 | $62,343,000 | +253.6% | 261,318 | -2.2% | 0.02% | +300.0% |
| Q2 2014 | $17,632,000 | -40.7% | 267,151 | -6.4% | 0.01% | -44.4% |
| Q1 2014 | $29,718,000 | -7.3% | 285,360 | -7.9% | 0.01% | -10.0% |
| Q4 2013 | $32,070,000 | +96.2% | 309,764 | +1.7% | 0.01% | +66.7% |
| Q3 2013 | $16,345,000 | +157.8% | 304,601 | +113.2% | 0.01% | +200.0% |
| Q2 2013 | $6,341,000 | – | 142,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |